1. De Giuseppe R, Braschi V, Bosoni D, et al. Dietary underreporting inwomen affected by polycystic ovary syndrome: a pilot study. Nutr Diet.2019;76(5):560-566. doi:10.1111/1747-0080.12460
2. Dokras A, Stener-Victorin E, Yildiz BO, et al. Androgen excess-polycystic ovary syndrome society: position statement ondepression, anxiety, quality of life, and eating disorders in polycysticovary syndrome. Fertil Steril. 2018;109(5):888-899. doi:10.1016/j.fertnstert.2018.01.038
3. Suchta K, Smolarczyk R, Czajkowski K, Rudnicka E, Kokoszka A.Binge eating disorder-the point prevalence among polish womenwith polycystic ovary syndrome and validity of screening tool for thispopulation. Int J Environ Res Public Health. 2022;20(1):546. doi:10.3390/ijerph20010546
4. Pirotta S, Barillaro M, Brennan L, et al. Disordered eating behavioursand eating disorders in women in australia with and without polycysticovary syndrome: a cross-sectional study. J Clin Med. 2019;8(10):1682.doi:10.3390/jcm8101682
5. Tay CT, Teede HJ, Hill B, Loxton D, Joham AE. Increased prevalence ofeating disorders, low self-esteem, and psychological distress in womenwith polycystic ovary syndrome: a community-based cohort study.Fertil Steril. 2019;112(2):353-361. doi:10.1016/j.fertnstert.2019.03.027
6. Cetik S, Acikgoz A, Yildiz BO. Investigation of taste function andeating behavior in women with polycystic ovary syndrome. Appetite.2022;168:105776. doi:10.1016/j.appet.2021.105776
7. Paganini C, Peterson G, Stavropoulos V, Krug I. The overlap betweenbinge eating behaviors and polycystic ovarian syndrome: an etiologicalintegrative model. Curr Pharm Des. 2018;24(9):999-1006. doi:10.2174/1381612824666171204151209
8. Karacan E, Caglar GS, Gürsoy AY, Yilmaz MB. Body satisfactionand eating attitudes among girls and young women with and withoutpolycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2014;27(2):72-77.doi:10.1016/j.jpag.2013.08.003.
9. Barrea L, Verde L, Vetrani C, Savastano S, Colao A, MuscogiuriG. Chronotype: a tool to screen eating habits in polycystic ovarysyndrome? Nutrients. 2022;14(5):955. doi:10.3390/nu14050955
10. Pitts S, Dahlberg SE, Gallagher JS, Gordon CM, DiVasta AD. Is ovarianreserve impacted in anorexia nervosa? J Pediatr Adolesc Gynecol.2021;34(2):196-202. doi:10.1016/j.jpag.2020.11.021
11. Greenwood EA, Pasch LA, Cedars MI, Huddleston HG. Obesity anddepression are risk factors for future eating disorder-related attitudesand behaviors in women with polycystic ovary syndrome. Fertil Steril.2020;113(5):1039-1049. doi:10.1016/j.fertnstert.2020.01.016
12. Söderqvist G, Naesse´n S. Androgens impact on psychopathologicalvariables according to CPRS, and EDI 2 scores: in women with bulimianervosa, and eating disorder not otherwise specified. J Steroid BiochemMol Biol. 2023;226:106217. doi:10.1016/j.jsbmb.2022.106217
13. Steegers-Theunissen RPM, Wiegel RE, Jansen PW, Laven JSE, SinclairKD. Polycystic ovary syndrome: a brain disorder characterized byeating problems originating during puberty and adolescence. Int J MolSci. 2020;21(21):8211. doi:10.3390/ijms21218211
14. Ilie IR. Neurotransmitter, neuropeptide, and gut peptide profile inPCOS pathways contributing to the pathophysiology, food intake andpsychiatric manifestations of PCOS. Adv Clin Chem. 2020;96:85-135.doi:10.1016/bs.acc.2019.11.004
15. Burnatowska E, Wikarek A, Oboza P, et al. Emotional eating andbinge eating disorders and night eating syndrome in polycystic ovarysyndrome-a vicious circle of disease: a systematic review. Nutrients.2023;15(2):295. doi:10.3390/nu15020295
16. Barberis N, Calaresi D, Cannavo` M, Verrastro V. Body mass indexand quality of life in individuals with polycystic ovary syndrome:dysmorphic concerns and eating disorders as mediators. Front PublicHealth. 2022;10:962083. doi:10.3389/fpubh.2022.962083
17. Rodino IS, Byrne S, Sanders KA. Disordered eating attitudes andexercise in women undergoing fertility treatment. Aust N Z J ObstetGynaecol. 2016;56(1):82-87. doi:10.1111/ajo.12407
18. Kolnikaj TS, Herman R, Janezˆ A, Jensterle M. Assessment of eatingdisorders and eating behavior to improve treatment outcomes inwomen with polycystic ovary syndrome. Life (Basel). 2022;12(11):1906.doi: 10.3390/life12111906
19. Stefanaki K, Karagiannakis DS, Raftopoulou M, Psaltopoulou T, PaschouSA, Ilias I. Obesity and hyperandrogenism are implicated with anxiety,depression, and food cravings in women with polycystic ovary syndrome.Endocrine. 2023;82(1):201-208. doi:10.1007/s12020-023-03436-1
20. Harada M. Pathophysiology of polycystic ovary syndrome revisited:current understanding and perspectives regarding future research.Reprod Med Biol. 2022;21(1):e12487. doi:10.1002/rmb2.12487
21. Risal S, Pei Y, Lu H, et al. Prenatal androgen exposure andtransgenerational susceptibility to polycystic ovary syndrome. NatMed. 2019;25(12):1894-1904. doi:10.1038/s41591-019-0666-1
22. Özgen Saydam B, Yıldız BO. Polycystic ovary syndrome and brain: anupdate on structural and functional studies. J Clin Endocrinol Metab.2021;106(2):e430-e441. doi:10.1210/clinem/dgaa843
23. Itriyeva K. The effects of obesity on the menstrual cycle. CurrProbl Pediatr Adolesc Health Care. 2022;52(8):101241. doi:10.1016/j.cppeds.2022.101241
24. Cesta CE, Ma§nsson M, Palm C, Lichtenstein P, Iliadou AN, Lande´n M.Polycystic ovary syndrome and psychiatric disorders: co-morbidity andheritability in a nationwide swedish cohort. Psychoneuroendocrinology.2016;73:196-203. doi:10.1016/ j.psyneuen.2016.08.005
25. Thannickal A, Brutocao C, Alsawas M, et al. Eating, sleeping andsexual function disorders in women with polycystic ovary syndrome(PCOS): a systematic review and meta-analysis. Clin Endocrinol (Oxf).2020;92(4):338-349. doi:10.1111/cen.14153
26. Ee C, Pirotta S, Mousa A, Moran L, Lim S. Providing lifestyle advice towomen with PCOS: an overview of practical issues affecting success.BMC Endocr Disord. 2021;21(1):234. doi:10.1186/s12902-021-00890-8
27. Yurci A, Dokuzeylül Güngör N, Güngör K, Hatırnaz Ş. Correlationof serum leptin and ghrelin levels with endocrine and reproductiveparameters in women with clomiphene citrate resistant polycystic ovarysyndrome. Turk J Obstet Gynecol. 2022:27;19(2):124-129. doi:10.4274/tjod.galenos.2022.84883
28. Annagür BB, Kerimoglu ÖS, Tazegül A, Gündüz Ş, Gençoglu BB.Psychiatric comorbidity in women with polycystic ovary syndrome. JObstet Gynaecol Res. 2015;41(8):1229-1233. doi:10.1111/jog.12696
29. Başar Gökcen B, Akdeveliogˆlu Y, Canan S, Bozkurt N. Increased riskof eating disorders in women with polycystic ovary syndrome: a case-control study. Gynecol Endocrinol. 2020;36(9):764-767. doi:10.1080/09513590.2020.1744554
30. Algars M, Huang L, Von Holle AF, et al. Binge eating and menstrualdysfunction. J Psychosom Res. 2014;76(1):19-22. doi:10.1016/j.jpsychores.2013.11.011
31. Krug I, Giles S, Paganini C. Binge eating in patients with polycysticovary syndrome: prevalence, causes, and management strategies.Neuropsychiatr Dis Treat. 2019;15:1273-1285. doi:10.2147/NDT.S168944
32. Garin MC, Butts SF, Sarwer DB, Allison KC, Senapati S, Dokras A.Ghrelin is independently associated with anti-mullerian hormone levelsin obese but not non-obese women with polycystic ovary syndrome.Endocrine. 2017;55(3):907-913. doi:10.1007/s12020-016-1210-4
33. Chen X, Kong L, Piltonen TT, Gissler M, Lavebratt C. Association ofpolycystic ovary syndrome or anovulatory infertility with offspringpsychiatric and mild neurodevelopmental disorders: a Finnishpopulation-based cohort study. Hum Reprod. 2020;35(10):2336-2347.doi: 10.1093/humrep/deaa192
34. Lee I, Cooney LG, Saini S, et al. Increased risk of disordered eatingin polycystic ovary syndrome. Fertil Steril. 2017;107(3):796-802.doi:10.1016/j.fertnstert.2016.12.014
35. Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, et al. Psychiatricdisorders in women with polycystic ovary syndrome. Psychiatr Pol.2019;53(4):955-966. doi:10.12740/PP/OnlineFirst/93105
36. Lee I, Cooney LG, Saini S, Sammel MD, Allison KC, Dokras A.Increased odds of disordered eating in polycystic ovary syndrome: asystematic review and meta-analysis. Eat Weight Disord. 2019;24(5):787-797. doi:10.1007/ s40519-018-0533-y
37. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management ofpolycystic ovary syndrome. Clin Epidemiol. 2013;6:1-13. doi:10.2147/CLEP.S37559
38. Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into theetiology, genetics, and immunology of polycystic ovarian syndrome(PCOS). J Assist Reprod Genet. 2022;39(11):2439-2473. doi:10.1007/s10815-022-02625-7
39. Jeanes YM, Reeves S, Gibson EL, Piggott C, May VA, Hart KH. Bingeeating behaviours and food cravings in women with polycystic ovarysyndrome. Appetite. 2017;109:24-32. doi:10.1016/j.appet.2016.11.010
40. Chudzicka-Strugala I, Gole?biewska I, Banaszewska B, Brudecki G,Zwoz´dziak B. The role of individually selected diets in obese womenwith PCOS-A review. Nutrients. 2022;14(21):4555. doi:10.3390/nu14214555